Myungshin Kim

Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome

Hereditary breast and ovarian cancer syndrome (HBOC) is caused by pathogenic variants in The Pathogenic variants in Multi-gene panel testing could be a significant screening tool for HBOC patients, especially for those with a family history of cancer.

Peripheral bloodBRCA1methylation profiling to predict familial ovarian cancer

Familial cancer appears at a young age and its incidence is increasing. About 12% of familial ovarian cancer cases are associated with Using peripheral blood DNA from 55 subjects without a history of cancer [cancer(-)] and 52 ovarian cancer patients, we examined Our data suggest a predictive role of

Cost-effective BRCA Testing in Advanced Ovarian Cancer